Randall B. Brenner - Net Worth and Insider Trading
Randall B. Brenner Net Worth
The estimated net worth of Randall B. Brenner is at least $925,916 dollars as of 2024-11-28. Randall B. Brenner is the Chief Development & Regulatory of Paratek Pharmaceuticals Inc and owns about 415,209 shares of Paratek Pharmaceuticals Inc (PRTK) stock worth over $925,916. Details can be seen in Randall B. Brenner's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Randall B. Brenner has not made any transactions after 2023-08-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Randall B. Brenner
Randall B. Brenner Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Randall B. Brenner owns 1 companies in total, including Paratek Pharmaceuticals Inc (PRTK) .
Click here to see the complete history of Randall B. Brenner’s form 4 insider trades.
Insider Ownership Summary of Randall B. Brenner
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PRTK | Paratek Pharmaceuticals Inc | 2023-09-21 | Chief Development & Regulatory |
Randall B. Brenner Latest Holdings Summary
Randall B. Brenner currently owns a total of 1 stock. Randall B. Brenner owns 415,209 shares of Paratek Pharmaceuticals Inc (PRTK) as of August 9, 2023, with a value of $925,916.
Latest Holdings of Randall B. Brenner
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PRTK | Paratek Pharmaceuticals Inc | 2023-08-09 | 415,209 | 2.23 | 925,916 |
Holding Weightings of Randall B. Brenner
Randall B. Brenner Form 4 Trading Tracker
According to the SEC Form 4 filings, Randall B. Brenner has made a total of 12 transactions in Paratek Pharmaceuticals Inc (PRTK) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Paratek Pharmaceuticals Inc is the sale of 27,603 shares on August 9, 2023, which brought Randall B. Brenner around $60,727.
Insider Trading History of Randall B. Brenner
- 1
Randall B. Brenner Trading Performance
Randall B. Brenner Ownership Network
Randall B. Brenner Owned Company Details
What does Paratek Pharmaceuticals Inc do?
Who are the key executives at Paratek Pharmaceuticals Inc?
Randall B. Brenner is the Chief Development & Regulatory of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and director & CEO Evan Loh .
Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary
Over the past 18 months, Randall B. Brenner made 1 insider transaction in Paratek Pharmaceuticals Inc (PRTK) with a net sale of 27,603. Other recent insider transactions involving Paratek Pharmaceuticals Inc (PRTK) include a net sale of 48,967 shares made by Evan Loh , a net sale of 34,526 shares made by William M. Haskel , and a net sale of 31,250 shares made by Michael Bigham .
In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 142,346 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 142,346 shares.
Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Paratek Pharmaceuticals Inc Insider Transactions
Randall B. Brenner Mailing Address
Above is the net worth, insider trading, and ownership report for Randall B. Brenner. You might contact Randall B. Brenner via mailing address: C/o Paratek Pharmaceuticals, Inc., 75 Park Plaza, 4th Floor, Boston Ma 02116.